Jones Financial Companies Lllp Raises Position in UnitedHealth Group Incorporated $UNH

Jones Financial Companies Lllp increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 30.1% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 87,961 shares of the healthcare conglomerate’s stock after buying an additional 20,375 shares during the period. Jones Financial Companies Lllp’s holdings in UnitedHealth Group were worth $45,587,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in UNH. Bayforest Capital Ltd grew its stake in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its stake in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 50 shares during the last quarter. Copia Wealth Management bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $42,000. IAG Wealth Partners LLC bought a new stake in shares of UnitedHealth Group in the first quarter worth about $42,000. Finally, Investment Management Corp VA ADV bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $44,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.3%

Shares of NYSE UNH opened at $352.61 on Monday. The firm’s 50-day moving average price is $291.98 and its 200-day moving average price is $368.31. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $319.35 billion, a price-to-earnings ratio of 15.28, a P/E/G ratio of 2.30 and a beta of 0.45. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

Wall Street Analyst Weigh In

Several research firms have weighed in on UNH. KeyCorp cut their price objective on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Wall Street Zen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. TD Cowen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price for the company. in a research report on Monday, May 19th. Truist Financial lifted their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Finally, HSBC reissued a “reduce” rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.